Page 6 - V Imaging News Today

Results from myocardial perfusion imaging of 2730 people with diabetes and no known coronary disease show impaired myocardial blood flow reserve predicts mortality regardless of ischemia symptoms.

Flurpiridaz has potential cost, convenience and ― especially for women and obese patients ― efficacy advantages over current PET perfusion methods.

Chronic kidney disease is associated with a more than sevenfold increase in the risk for sudden cardiac arrest among US residents of Hispanic or Latinx ethnicity, new data suggest.

Transcatheter aortic valve replacement with intracardiac echocardiography using a transjugular approach is feasible and safe, preliminary results show.

Filling an evidence gap, a pooled analysis of patients with heart failure across the LVEF spectrum supports starting sacubitril-valsartan in the hospital.

The TENSION trial, which was stopped early for efficacy, selected patients using widely available non-contrast CT or CT angiography and should lead to more patients being considered for treatment.

An otherwise negative trial may have identified a subgroup of patients likely to respond well to this potential transcatheter therapy for heart failure.

Were the GLP-1 receptor agonist drugs apparent benefits in STEP-HFpEF due solely to weight loss or additional mechanisms? The trial offers a clue, experts say.

Four experts explain nuances of the multidrug strategy and why it should be easy to implement. Given its slow uptake in practice, what forces are conspiring against it?

Tapering is best reserved for those in complete remission with stable disease for at least 6 months, although many individual patient characteristics must be taken into account, experts say.